SCHEMBL8200547

SCHEMBL8200547

CC(C)(C)CCNC(=O)c1ccc2c(c1)CCC(CCN1CCC(c3ccccc3)CC1)C2=O

nearest known ligand 0.48

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 6/20 0.48
DRD2 P14416 2/20 0.44
MCHR1 Q99705 1/20 0.42
OPRM1 P35372 1/20 0.42
OPRK1 P41145 1/20 0.42
USP5 P45974 3/20 0.42
KCNH2 Q12809 2/20 0.40
CACNA1I Q9P0X4 2/20 0.40
DRD3 P35462 2/20 0.40
NAMPT P43490 1/20 0.40
SIGMAR1 Q99720 1/20 0.39
DRD4 P21917 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8588802 0.91 HTR2C (0.48) HTR2CDRD2MCHR1OPRM1OPRK1
SCHEMBL8200268 0.88 HTR2C (0.46) HTR2CDRD2MCHR1OPRM1OPRK1
SCHEMBL8199972 0.88 HTR2C (0.46) HTR2CDRD2MCHR1OPRM1OPRK1
SCHEMBL8198570 0.88 HTR2C (0.47) HTR2CDRD2OPRM1OPRK1SIGMAR1
SCHEMBL8202320 0.87 USP5 (0.52) HTR2CDRD2MCHR1USP5SIGMAR1
SCHEMBL8198781 0.87 HTR2C (0.46) HTR2CDRD2MCHR1DRD3SIGMAR1
SCHEMBL8201705 0.87 HTR2C (0.46) HTR2CDRD2MCHR1OPRM1OPRK1
SCHEMBL8199804 0.86 HTR2C (0.49) HTR2CDRD2MCHR1OPRM1OPRK1
SCHEMBL8203525 0.86 SIGMAR1 (0.46) HTR2CSIGMAR1DRD4
SCHEMBL8589689 0.85 HTR2C (0.44) HTR2CDRD2MCHR1OPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6048877-A Tetralone derivatives as antiarrhythmic agents BRISTOL-MYERS SQUIBB COMPANY (US) 2000-04-11 US claimed
WO-1998036749-A1 TETRALONE DERIVATIVES AS ANTIARRHYTHMIC AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-08-27 WO claimed
US-6048877-A Tetralone derivatives as antiarrhythmic agents BRISTOL-MYERS SQUIBB COMPANY (US) 2000-04-11 US disclosed